SENSEX NIFTY

Biocon

Oct 22, 2014 at 16:56 | Source: PTI
Consolidated total income from operations of Biocon rose to Rs 757.59 crore for the quarter under consideration as against Rs 740.81 crore for the same period a year ago.
Oct 22, 2014 at 08:45 | Source: CNBC-TV18
Here are Top 10 stocks to focus on October 22 Cairn India, Federal Bank, CESC, Biocon, KPIT Tech, Mcleod Russel, DHFL, Guj Fluoro, BASF, Mangalore Chemicals.
Oct 22, 2014 at 08:26 | Source: CNBC-TV18
Cairn India | Maruti Suzuki | Sesa Sterlite | Wipro | HDFC | Asian Paints | Kotak Mahindra Bank | Havells India | Gujarat Fluorochemicals | KPIT Technologies | SKF India | BASF India | DHFL | Zensar Technologies | GNFC | McLeod Russel | Larsen and Toubro | Sadbhav Engineering and TCS are stocks, which are in the news today.
Oct 21, 2014 at 10:46 | Source: CNBC-TV18
Pharmaceutical firm Biocon, which will declare its second quarter earnings today, is expected to report a 9 percent rise in profit at Rs 111.3 crore compared to Rs 102.15 crore in the year-ago period.
Oct 21, 2014 at 08:35 | Source: CNBC-TV18
HDFC Bank | PNB | Cairn India | Idea Cellular | Coal India | Just Dial | HCL Infosystems | Shriram Transport | SKS Microfinance | Sasken Communication | ITDC | Heritage Foods | Zee Media | Motilal Oswal Financial Services | Vascon Engg | BGR Energy | Goa Carbon | UltraTech Cements and Lakshmi Vilas Bank are stocks, which are in the news today.
Oct 13, 2014 at 09:08 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com believes despite the recent fall in the market for the past three consecutive weeks, it is not over yet. He feels Nifty will see resistance at 7950.
Oct 10, 2014 at 08:23 | Source: CNBC-TV18
AK Prabhakar, Independent Advisor advises buying Havells India for a target price of Rs 298 and L&T Finance Holdings for a target price of Rs 75.
Oct 09, 2014 at 15:46 | Source: CNBC-TV18
In an interview to CNBC-TV18, alpha manager Vetri Subramaniam, Chief Investment Officer, Religare Invesco Mutual Fund, says he has been seeing a mild recovery in the economic growth, but feels the government needs to now focus on policy implementation.
Oct 07, 2014 at 08:27 | Source: CNBC-TV18
Gaurav Ratnaparkhi of Sharekhan advises buying Exide Industries with a target of Rs 183 and UCO Bank with a target of Rs 85.50.
Oct 01, 2014 at 12:32 | Source: Moneycontrol.com
Biocon Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 21, 2014, inter alia, to approve and take on record the unaudited financial results of the Company for the quarter and half year ended September 30, 2014 (Q2).
Messages on Biocon »

subs74

Silver Member

3 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th

ScorpioKing
-KD

Gold Member

108 Followers

Biocon  

Any specific relation would have to seen in main budget - my point was that if overall market tanks badly - Biocon wont be exception. Not necessarily related to biocon. Long due correction in market.

3.52 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th

namo8081

New Member

3 Followers

Biocon  

kal biocon 520 ke niche milega

2.56 PM Jul 8th

dr.sachin

New Member

0 Follower

Biocon  

biocon has nothing to do with railway budget still creeping down

1.54 PM Jul 8th

hrasvs

New Member

1 Followers

Biocon  

may biocon taste 650 lvl by end aug14.

12.31 PM Jul 8th

BSE/NSE Announcer

Platinum Member

4697 Followers

Biocon  

Biocon Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.08 AM Jul 8th

sanecounsel

Platinum Member

76 Followers

Biocon  

the outcome of the Delhi High Court case brought by Roche against Biocon and Mylan in February gains significance. Roche has alleged that Biocon/Mylan has misrepresented its drugs as a biosimilar of its bestselling breast cancer drug, Trastuzumab (Herceptin), without having undergone the required

10.04 AM Jul 8th

niceworld

Platinum Member

4229 Followers

Granules India  

`t care because I do believe this and the results have been terrific till now in my life.There are many examples.Biocon was one of such examples... contd.

10.21 PM Jul 7th

neo_ice

New Member

0 Follower

Biocon  

heavy buying seen at day`s end with high volumes .... brakout pattern from all time high also suggests eminent rise - My target for Biocon is Rs 580 for the short term

3.43 PM Jul 7th

News across the web »
Sep 25, 2014 at 10:47 | Source: Zee Business
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.